AstraZeneca-Sanofi RSV shot for children approved by FDA

The United States Food and Drug Administration (FDA) approved on Monday Beyfortus or nirsevimab, a medicine developed by AstraZeneca plc and Sanofi SA used to prevent respiratory syncytial virus (RSV)…